Description: The cell and gene therapy marketplace is quickly evolving and continues to grow as a risk concern for governments, health plans, stop loss insurers and reinsurers. In this webinar, we discuss currently approved tissue, cell and gene therapies, the near-term pipeline, uptake considerations, case management processes, plan document and contract considerations, risk mitigation processes and programs, and network considerations.

Description: The editor of Health Watch previews the articles in this issue.

Description: Listing of articles of interest to SIPF Section members from the January 2010 issue of In The Public Interest.

Description: Article from The Actuary, May 1971 – volume 5 - Issue 5 is an extract from a recently discovered Dead Sea Scroll regarding language to be included in a prospectus to provide potential investors with an adequate basis for judging the offering.

Description: This session from the 1995 SOA New York City Meeting discusses the Standard and Poor's or S&P's rating process, the qualitative and quantitative factors to determine a company's rating. From the Record of the Society of Actuaries, Vol. 21, No. 2.

Description: This article describes the new state of Washington regulation governing replacements noting problems with the formula used and offering improvements.

Description: The Regulation and Taxation e-course covers the regulatory environment of life and annuity insurance in Taiwan.

Description: Company Considerations and Regulatory Perspective for Offering Reduced Benefit Options

Description: Arguments for establishing a monetary system based on an aggregate commodity standard.

Description: Budget concerns should not be allowed to override sound actuarial rate development in setting Medicaid capitation rates.